Literature DB >> 18075745

Comparative evaluation of 5-HIAA (5-hydroxy indoleacetic acid) and HVA (homovanillic acid) in infantile hydrocephalus.

S C Gopal1, A Pandey, I Das, A N Gangopadhyay, V D Upadhyaya, J P N Chansuria, T B Singh.   

Abstract

BACKGROUND: Infantile hydrocephalus is a common congenital problem. Functional and behavioral disturbances associated with hydrocephalus may be due to altered neurotransmitters in the brain. The role of neurotransmitters has been established in various psychiatric and neurological conditions. Therefore, we decided to study the role of 5-hydroxy indoleacetic acid (5-HIAA) and homovanillic acid (HVA) in cerebrospinal fluid (CSF) of hydrocephalic patients as diagnostic and prognostic marker.
MATERIALS AND METHODS: Ventricular CSF samples were taken from hydrocephalic patients peroperatively and at days 7 & 30. Control CSF samples were taken from nonhydrocephalic patients operated for other conditions. Samples were analyzed for 5-HIAA and HVA, and results were obtained accordingly.
RESULTS: Values of 5-HIAA and HVA showed a highly significant decrease after shunt insertion. No significant difference in values of 5-HIAA and HVA were observed in relation to age and duration of disease. The CSF ventriculo-lumbar gradient for both 5-HIAA and HVA done in six patients was statistically significant only in the noncommunicating group.
CONCLUSION: Both the neurotransmitter metabolites 5-HIAA and HVA are found to be significantly high in the hydrocephalus, but 5-HIAA is a more sensitive parameter. These markers levels decrease after shunt insertion. Thus, estimation of these metabolites could be valuable markers for its diagnosis and follow-up.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18075745     DOI: 10.1007/s00381-007-0546-8

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  15 in total

1.  Effect of tryptophan administration on 5HIAA in cerebrospinal fluid in man.

Authors:  D Eccleston; G W Ashcroft; T B Crawford
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-04       Impact factor: 10.154

2.  Amine metabolites in the lumbar cerebrospinal fluid of humans with restricted flow of cerebrospinal fluid.

Authors:  G Curzon; E J Gumpert; D M Sharpe
Journal:  Nat New Biol       Date:  1971-06-09

3.  Acidic monoamine metabolites in cerebrospinal fluid of children with hydrocephalus.

Authors:  H Andersson; B E Roos
Journal:  Acta Neurol Scand Suppl       Date:  1965

4.  Neurotransmitter markers in the cerebrospinal fluid of normal subjects. Effects of aging and other confounding factors.

Authors:  P Hartikainen; H Soininen; K J Reinikainen; J Sirviö; R Soikkeli; P J Riekkinen
Journal:  J Neural Transm Gen Sect       Date:  1991

5.  Metabolic fate of l-[14C] DOPA in cerebrospinal fluid and blood plasma of humans.

Authors:  A Pletscher; G Bartholini; R Tissot
Journal:  Brain Res       Date:  1967-02       Impact factor: 3.252

6.  [Age changes in concentrations of monoamines and related substances in the cerebrospinal fluid].

Authors:  S Takahashi; T Abe
Journal:  No To Shinkei       Date:  1991-04

7.  Homovanillic acid and 5-hydroxyindole-acetic acid in the csf of patients after a severe head injury. I. Lumbar csf concentration in chronic brain post-traumatic syndromes.

Authors:  S R Bareggi; M Porta; A Selenati; B M Assael; G Calderini; M Collice; M Rossanda; P L Morselli
Journal:  Eur Neurol       Date:  1975       Impact factor: 1.710

8.  Homovanillic acid and 5-hydroxyindole-acetic acid in the csf of patients after a severe head injury. II. Ventricular csf concentrations in acute brain post-traumatic syndromes.

Authors:  M Porta; S R Bareggi; M Collice; B M Assael; A Selenati; G Calderini; M Rossanda; P L Morselli
Journal:  Eur Neurol       Date:  1975       Impact factor: 1.710

9.  Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism.

Authors:  M Narayan; S Srinath; G M Anderson; D B Meundi
Journal:  Biol Psychiatry       Date:  1993 Apr 15-May 1       Impact factor: 13.382

10.  Homovanillic acid and 5-hydroxyindoleacetic acid modifications in CSF of patients with stroke and multi-infarct dementia.

Authors:  S Smirne; M Franceschi; G Truci; M Camerlingo; R Pirola; L Ferini-Strambi; S R Bareggi
Journal:  Stroke       Date:  1985 Nov-Dec       Impact factor: 7.914

View more
  2 in total

1.  Serotonin metabolites in the cerebrospinal fluid in sudden infant death syndrome.

Authors:  Ingvar J Rognum; Hoa Tran; Elisabeth A Haas; Keith Hyland; David S Paterson; Robin L Haynes; Kevin G Broadbelt; Brian J Harty; Othon Mena; Henry F Krous; Hannah C Kinney
Journal:  J Neuropathol Exp Neurol       Date:  2014-02       Impact factor: 3.685

2.  Cerebrospinal fluid biomarkers of infantile congenital hydrocephalus.

Authors:  David D Limbrick; Brandon Baksh; Clinton D Morgan; Gakwaya Habiyaremye; James P McAllister; Terrie E Inder; Deanna Mercer; David M Holtzman; Jennifer Strahle; Michael J Wallendorf; Diego M Morales
Journal:  PLoS One       Date:  2017-02-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.